Noncaspase proteases in apoptosis

Leukemia

Volumn 14, Issue 9, 2000, Pages 1695-1703

  Johnson, D E ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Calpain; Cathepsin B; Cathepsin D; Granzyme A; Granzyme B

Indexed keywords

CA 074; CALCIMYCIN; CALPAIN; CARBOXYPEPTIDASE C; CASPASE 2; CASPASE 3; CASPASE 9; CATHEPSIN; CATHEPSIN B; CATHEPSIN D; CATHEPSIN E; CATHEPSIN G; CATHEPSIN K; CATHEPSIN L; CATHEPSIN S; COLLAGEN; DIPEPTIDYL PEPTIDASE I; DOXORUBICIN; ESTROGEN; FIBRONECTIN; FODRIN; GAMMA INTERFERON; GELSOLIN; GRANZYME B; PEPSTATIN; PROTEIN KINASE (CALCIUM,CALMODULIN); PROTEINASE; PROTEINASE INHIBITOR; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; [1 [(1 FORMYL 2 PHENYLETHYL)CARBAMOYL] 2 METHYLPROPYL]CARBAMIC ACID BENZYL ESTER;

ALZHEIMER DISEASE; ANIMAL CELL; APOPTOSIS; BREAST CANCER; BURKITT LYMPHOMA; CAENORHABDITIS ELEGANS; CELL MIGRATION; CELL VIABILITY; CELLULAR DISTRIBUTION; COLLAGEN DEGRADATION; CYTOPATHOGENIC EFFECT; DNA DAMAGE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LOCALIZATION; EXTRACELLULAR MATRIX; GENETIC ANALYSIS; HUMAN; HUMAN CELL; METASTASIS POTENTIAL; NONHUMAN; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DEGRADATION; RAT; REVIEW; SIGNAL TRANSDUCTION; TARGET CELL;

EID: 0033832629     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401879     Document Type: Review

References (162)

1. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme
2. Molecular cloning of the interleukin-1β converting enzyme
3. A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes
4. Human ICE/CED-3 protease nomenclature
5. Caspases: Enemies within
6. The role of the ubiquitin-proteasome pathway in apoptosis
7. Tissue cathepsins as tumor markers
8. Emerging roles for cysteine proteases in human biology
9. A secreted glycoprotein induced by estrogen in human breast cancer cell lines
10. Increased secretion, altered processing and glycosylation of procathepsin D in mammary cancer cells
11. Biosynthesis of lysosomal endopeptidases
12. Isolation and sequencing of a cDNA clone encoding rat liver lysosomal cathepsin D and the structure of three forms of mature enzymes
13. Biosynthesis and intracellular targeting of the lysosomal aspartic proteinase cathepsin D
14. The role of apoptosis in the pathogenesis, prognosis, and therapy of hematologic malignancies
15. Interrelationship of active and latent secreted human cathepsin B precursors
16. Cysteine proteinases and metastasis
17. In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells
18. Cathepsin D in the malignant progression of neoplastic disease
19. Biology and biochemistry of proteinases in tumor invasion
20. Association between high concentration of 52-kDa cathepsin D and poor prognosis in primary human breast cancer
21. Cathepsin D and prognosis in breast cancer
22. Cathepsin D as a prognostic indicator of node-negative breast cancer patients using both immunoassays and enzymatic assays
23. Biological and clinical significance of cathepsin D in breast cancer metastasis
24. Relationship between DNA fragmentation and apoptosis in programmed cell death in the rat prostate following castration
25. Cell death by apoptosis during involution of the lactating breast in mice and rats
26. Cathepsin B, a cysteine protease implicated in metastatic progression, is also expressed during regression of the rat prostate and mammary glands
27. Characterization of castration-induced cell death in the rat prostate by immunohisto-chemical localization of cathepsin D
28. Cathepsin B contributes to bile salt-induced apoptosis of rat hepatocytes
29. Cathepsins as effector proteases in hepatocyte apoptosis
30. Identification of latent cathepsins B and L in microsomal lumen: Characterization of enzymatic activation and proteolytic processing in vitro
31. Rat procathepsin B: Proteolytic processing to the mature form in vitro
32. Participation of cathepsins B and D in apoptosis of PC12 cells following serum deprivation
33. Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: Evidence for early up-regulation of the endosomal-lysosomal system
34. Regulation of a novel pathway for cell death by lysosomal aspartic and cysteine proteinases
35. Control of apoptosis in hematopoiesis and leukemia by cytokines, tumor suppressor and oncogenes
36. Cytokine response profiles of human myeloid factor-dependent leukemia cell lines
37. IL-3 withdrawal activates a CrmA-insensitive poly(ADP-ribose) polymerase cleavage enzyme in factor-dependent myeloid progenitor cells
38. Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: Possible sites for intervention with anti-neoplastic drugs
39. Cathepsin D protease mediates programmed cell death induced by interferon-γ, Fas/APO-1 and TNF-α
40. Potential role for cathepsin D in p53-dependent tumor suppression and chemosensitivity
41. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death
42. Cleavage of BID by caspase 8 mediates the mitochondrial damage in Fas pathway of apoptosis
43. Cytotoxic drugs and the CD95 pathway
44. The Bcl-2 protein family: Arbiters of cell survival
45. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis
46. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD
47. Mechanisms of apoptotic cell death
48. Suicidal tendencies: Apoptotic cell death by caspase family proteinases
49. Lethal hydrogen peroxide toxicity involves lysosomal iron-catalyzed reactions with membrane damage
50. Uptake of oxidized LDL by macrophages results in partial lysosomal enzyme inactivation and relocation
51. Oxidative stress causes relocation of the lysosomal enzyme cathepsin D with ensuing apoptosis in neonatal rat cardiomyocytes
52. Atractyloside-induced release of cathepsin B, a protease with caspase-processing activity
53. Activation of pro-caspase-7 by serine proteases includes a non-canonical specificity
54. Non-specific effects of methyl ketone peptide inhibitors of caspases
55. A neutral, calcium-activated proteinase from the soluble fraction of rat brain
56. Canine cardiac calcium-dependent proteases: Resolution of two forms with different requirements for calcium
57. Intracellular Ca2+-dependent protease (calpain) and its high-molecular-weight endogenous inhibitor
58. New era of calpain research: Discovery of tissue-specific calpains
59. Calpain: A protease in search of a function?
60. A novel tissue-specific calpain species expressed predominantly in the stomach comprises two alternative splicing products with and without Ca(2+)-binding domain
61. Muscle-specific calpain, p94, is degraded by autolysis immediately after translation, resulting in disappearance from muscle
62. 2.2 Mb of contiguous nucleotide sequence from chromosome III of C. elegans
63. Similarity and dissimilarity in subunit structures of calpains I and II from various sources as demonstrated by immunological cross-reactivity
64. Intracellular regulatory system involving calpain and calpastatin
65. Calcium-activated neutral protease (calpain) system: Structure, function, and regulation
66. Structure of a calpain Ca(2+)-binding domain reveals a novel EF-hand and Ca(2+)-induced conformational changes
67. Ca(2+)-activated neutral protease is active in the erythrocyte membrane in its nonautolyzed 80-kDa form
68. Autolysis of calcium-activated neutral protease of chicken skeletal muscle
69. Rabbit skeletal muscle calcium-dependent protease requiring millimolar CA2+. Purification, subunit structure, and Ca2+-dependent autoproteolysis
70. Autoproteolysis of the small subunit of calcium-dependent protease II activates and regulates protease activity
71. Limited autolysis of calcium-activated neutral protease (CANP): Reduction of the Ca2+-requirement is due to the NH2-terminal processing of the large subunit
72. Activation mechanism of calcium-activated neutral protease. Evidence for the existence of intramolecular and intermolecular autolyses
73. Autolysis, Ca2+ requirement, and heterodimer stability in m-calpain
74. Identification of two protease inhibitors from bovine cardiac muscle
75. Endogenous inhibitor for calcium-dependent cysteine protease contains four internal repeats that could be responsible for its multiple reactive sites
76. Calpain activation in apoptosis
77. Constitutive apoptosis in human neutrophils requires synergy between calpains and the proteosome downstream of caspases
78. Calpain activation is upstream of caspases in radiation-induced apoptosis
79. Caspase-dependent activation of calpain during drug-induced apoptosis
80. Ceramide selectively decreases tau levels in differentiated PC12 cells through modulation of calpain I
81. Reovirus-induced apoptosis is preceded by increased cellular calpain activity and is blocked by calpain inhibitors
82. Calpain mediates ishemic injury of the liver through modulation of apoptosis and necrosis
83. Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: A potential molecular basis for neuronal degeneration
84. Calcium-activated neutral proteinase (calpain) system in aging and Alzheimer's disease
85. Increased M-calpain expression in the mesencephalon of patients with Parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon: A role in nerve cell death?
86. Leupeptins, new protease inhibitors from Actinomycetes
87. E-64 [L-trans-epoxysuccinyl-leucyl-amido(4-guanidino)butane] and related epoxides as inhibitors of cysteine proteinases
88. Developing selective inhibitors of calpain
89. Cell-penetrating inhibitors of calpain
90. Synthesis of a new cell penetrating inhibitor
91. An alpha-mercaptoacrylic acid derivative is a selective non-peptide cell-permeable calpain inhibitor and is neuroprotective
92. Calpain, an upstream regulator of thymocyte apoptosis
93. Calpain and calpastatin regulate neutrophil apoptosis
94. Protease involvement in fodrin cleavage and phosphatidylserine exposure in apoptosis
95. Calpain involvement in calphostin C-induced apoptosis
96. Calpain functions in a caspase-independent manner to promote apoptosis-like events during platelet activation
97. Attenuation of TGF-beta-induced apoptosis in primary cultures of hepatocytes by calpain inhibitors
98. Calpain inhibitors, but not caspase inhibitors, prevent actin proteolysis and DNA fragmentation during apoptosis
99. Role of calpain- and interleukin-1β converting enzyme-like proteases in the β-amyloid-induced death of rat hippocampal neurons in culture
100. Calpain regulation of cytoskeletal signaling complexes in von Wille-brand factor-stimulated platelets. Distinct roles for glycoprotein lb-V-IX and factor-induced signal transduction
101. Proteolysis of fodrin (non-erythroid spectrin) during apoptosis
102. Focal adhesion kinase (pp125FAK) cleavage and regulation by calpain
103. 3 subunit during endothelial cell apoptosis
104. Limited proteolysis of protein kinase C subspecies by calcium-dependent neutral protease
105. Calcium/calmodulin-dependent protein kinase IV is cleaved by caspase-3 and calpain in SH-SY5Y human neuroblastoma cells undergoing apoptosis
106. Specific proteolysis of the c-mos proto-oncogene product by calpain on fertilization of Xenopus eggs
107. Degradation of transcription factors, c-Jun and c-Fos, by calpain
108. Specific cleavage of transcription factors by the thiol protease, m-calpain
109. Regulation of cyclin D1 by calpain protease
110. Proteolytic cleavage of human p53 by calpain: A potential regulator of protein stability
111. Bax cleavage is mediated by calpain during drug-induced apoptosis
112. Cleavage of the calpain inhibitor, calpastatin, during apoptosis
113. Caspase-mediated fragmentation of calpain inhibitor protein calpastatin during apoptosis
114. The CTL's kiss of death
115. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo
116. The Fas death factor
117. Death receptors: Signaling and modulation
118. Cell-mediated cytotoxicity
119. Natural killer and lymphokine-activated killer cells require granzyme B for the rapid induction of apoptosis in susceptible target cells
120. Granzyme B plays a critical role in cytotoxic lymphocyte-induced apoptosis
121. Isolation of a lytic pore-forming protein (perforin) from cytolytic T lymphocytes
122. Purification and characterization of a cytolytic pore-forming protein from granules of cloned lymphocytes with natural killer activity
123. Phosphorylcholine acts as a calcium dependent receptor molecule for lymphocyte perforin
124. Granzymes: A variety of serine protease specificities encoded by genetically distinct subfamilies
125. RNKP-1, a novel natural killer cell-associated serine protease gene cloned from RNK-16 cytotoxic lymphocytes
126. Cloning of two genes that are specifically expressed in activated cytotoxic T lymphocytes
127. Human and murine cytotoxic T lymphocyte serine proteases: Subsite mapping with peptide thioester substrates and inhibition of enzyme activity and cytolysis by isocoumarins
128. Human cytotoxic lymphocyte granzyme B: Its purification from granules and the characterization of substrate and inhibitor specificity
129. A natural killer cell granule protein that induces DNA fragmentation and apoptosis
130. Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells
131. New paradigm for lymphocyte granule-mediated cytotoxicity. Target cells bind and internalize granzyme B, but an endosomolytic agent is necessary for cytosolic delivery and subsequent apoptosis
132. Nuclear transport of granzyme B (fragmentin-2)
133. Granzyme B (GraB) autonomously crosses the cell membrane and perforin initiates apoptosis and GraB nuclear localization
134. Entry and trafficking of granzyme B in target cells during granzyme B-perforin-mediated apoptosis
135. Nuclear translocation of granzyme B in target cell apoptosis
136. Binding of granzyme B in the nucleus of target cells. Recognition of an 80-kilodalton protein
137. Localization of granzyme B in the nucleus. A putative role in the mechanism of cytotoxic lymphocyte-mediated apoptosis
138. Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B
139. Cleavage of CPP32 by granzyme B represents a critical role for granzyme B in the induction of target cell DNA fragmentation
140. The cytotoxic cell protease granzyme B initiates apoptosis in a cell-free system by proteolytic processing and activation of the ICE/CED-3 family protease, CPP32, via a novel two-step mechanism
141. Proteolytic activation of the cell death protease Yama/CPP32 by granzyme B
142. Mch2, a new member of the apoptotic Ced-3/Ice cysteine protease gene family
143. The CED-3/ICE-like protease Mch2 is activated during apoptosis and cleaves the death substrate lamin A
144. Mch3, a novel human apoptotic cysteine protease highly related to CPP32
145. Cytotoxic T cell-derived granzyme B activates the apoptotic protease ICE-LAP3
146. Processing and activation of CMH-1 by granzyme B
147. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF-receptor-induced cell death
148. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex
149. ICE-LAP6, a novel member of the ICE/Ced-3 gene family, is activated by the cytotoxic T cell protease granzyme B
150. In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains
151. Cleavage of FLICE (caspase-8) by granzyme B during cytotoxic T lymphocyte-induced apoptosis
152. Cleavage of caspase family members by granzyme B: A comparative study in vitro
153. Granule-mediated killing: Pathways for granzyme B-initiated apoptosis
154. Activation of an interleukin 1 converting enzyme-dependent apoptosis pathway by granzyme B
155. Granzyme B directly and efficiently cleaves several downstream caspase substrates: Implications for CTL-induced apoptosis
156. Cloning of a cDNA for a T cell specific serine protease from a cytotoxic T lymphocyte
157. Identification of granzyme A isolated from cytotoxic T-lymphocyte-granules as one of the proteases encoded by CTL-specific genes
158. Granzyme A-deficient mice retain potent cell-mediated cytotoxicity
159. Granzyme A is critical for recovery of mice from infection with the natural cytopathic viral pathogen, ectromelia
160. Granzyme A initiates an alternative pathway for granule-mediated apoptosis
161. Induction of target cell DNA release by the cytotoxic T lymphocyte granule protease granzyme A
162. Granzyme A loading induces rapid cytolysis and a novel form of DNA damage independently of caspase activation